The number of patients in dialysis increases every year. In this review, we will evaluate the
role of percutaneous transluminal angioplasty (PTA) according to patency of arteriovenous …

Background Thrombosis following stenosis of arteriovenous fistulae resulting in the loss of
vascular access for hemodialysis is an important complication in patients with chronic renal …

Purpose To evaluate the effect of percutaneous transluminal angioplasty (PTA) on
haemodialysis fistulas utilising drug-coated balloons with plain balloon vessel preparation …

Percutaneous transluminal angioplasty (PTA) is an established treatment for dysfunctional
hemodialysis fistulas. This article systematically reviews evidence for predictors of patency …

Purpose To compare lesion primary patency and restenosis rates between drug-eluting
balloon (DEB) percutaneous transluminal angioplasty (PTA) and conventional balloon PTA …

Objective: To evaluate the initial clinical success and long-term patency rates of
percutaneous transluminal angioplasty (PTA) using a venous approach for dysfunctional …

Background The initial therapy for a stenosis in an arteriovenous fistula used for
haemodialysis is radiological balloon dilatation or angioplasty. The benefit of angioplasty is …

Purpose To investigate the potential added value of paclitaxel-coated balloon (PCB)
angioplasty to reduce fistula dysfunction related to recurrent stenoses in patients undergoing …

Background: Endovascular treatment of autogenous arteriovenous haemodialysis fistula
stenosis has high reintervention rates. We investigate the effect of drug-eluting balloons in …

The technique of percutaneous transluminal angioplasty (PTA) has become routinely used
in the management of hemodialysis access dysfunction. It is used for the management of …